vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.
Tecnoglass Inc. is the larger business by last-quarter revenue ($245.3M vs $164.7M, roughly 1.5× PTC THERAPEUTICS, INC.). Tecnoglass Inc. runs the higher net margin — 10.6% vs -82.0%, a 92.6% gap on every dollar of revenue. On growth, Tecnoglass Inc. posted the faster year-over-year revenue change (2.4% vs -22.7%). Tecnoglass Inc. produced more free cash flow last quarter ($11.4M vs $-36.6M). Over the past eight quarters, Tecnoglass Inc.'s revenue compounded faster (12.8% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.
PTCT vs TGLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $245.3M |
| Net Profit | $-135.0M | $26.1M |
| Gross Margin | — | 40.0% |
| Operating Margin | -43.3% | 18.3% |
| Net Margin | -82.0% | 10.6% |
| Revenue YoY | -22.7% | 2.4% |
| Net Profit YoY | -104.8% | -44.5% |
| EPS (diluted) | $-1.63 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | $245.3M | ||
| Q3 25 | $211.0M | $260.5M | ||
| Q2 25 | $178.9M | $255.5M | ||
| Q1 25 | $1.2B | $222.3M | ||
| Q4 24 | $213.2M | $239.6M | ||
| Q3 24 | $196.8M | $238.3M | ||
| Q2 24 | $186.7M | $219.7M | ||
| Q1 24 | $210.1M | $192.6M |
| Q4 25 | $-135.0M | $26.1M | ||
| Q3 25 | $15.9M | $47.2M | ||
| Q2 25 | $-64.8M | $44.1M | ||
| Q1 25 | $866.6M | $42.2M | ||
| Q4 24 | $-65.9M | $47.0M | ||
| Q3 24 | $-106.7M | $49.5M | ||
| Q2 24 | $-99.2M | $35.0M | ||
| Q1 24 | $-91.6M | $29.7M |
| Q4 25 | — | 40.0% | ||
| Q3 25 | — | 42.7% | ||
| Q2 25 | — | 44.7% | ||
| Q1 25 | — | 43.9% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 45.8% | ||
| Q2 24 | — | 40.8% | ||
| Q1 24 | — | 38.8% |
| Q4 25 | -43.3% | 18.3% | ||
| Q3 25 | 1.4% | 25.1% | ||
| Q2 25 | -19.5% | 24.0% | ||
| Q1 25 | 82.5% | 26.7% | ||
| Q4 24 | -76.2% | 28.0% | ||
| Q3 24 | -27.7% | 28.4% | ||
| Q2 24 | -21.5% | 23.3% | ||
| Q1 24 | -21.6% | 21.3% |
| Q4 25 | -82.0% | 10.6% | ||
| Q3 25 | 7.5% | 18.1% | ||
| Q2 25 | -36.3% | 17.3% | ||
| Q1 25 | 73.7% | 19.0% | ||
| Q4 24 | -30.9% | 19.6% | ||
| Q3 24 | -54.2% | 20.8% | ||
| Q2 24 | -53.1% | 15.9% | ||
| Q1 24 | -43.6% | 15.4% |
| Q4 25 | $-1.63 | $0.57 | ||
| Q3 25 | $0.20 | $1.01 | ||
| Q2 25 | $-0.83 | $0.94 | ||
| Q1 25 | $10.04 | $0.90 | ||
| Q4 24 | $-0.85 | $1.00 | ||
| Q3 24 | $-1.39 | $1.05 | ||
| Q2 24 | $-1.29 | $0.75 | ||
| Q1 24 | $-1.20 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $104.1M |
| Total DebtLower is stronger | — | $174.4M |
| Stockholders' EquityBook value | $-205.3M | $713.1M |
| Total Assets | $2.9B | $1.3B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $104.1M | ||
| Q3 25 | $1.7B | $127.1M | ||
| Q2 25 | $2.0B | $140.9M | ||
| Q1 25 | $2.0B | $160.2M | ||
| Q4 24 | $1.1B | $137.5M | ||
| Q3 24 | $1.0B | $124.8M | ||
| Q2 24 | $1.1B | $129.5M | ||
| Q1 24 | $884.8M | $138.8M |
| Q4 25 | — | $174.4M | ||
| Q3 25 | — | $114.7M | ||
| Q2 25 | — | $110.6M | ||
| Q1 25 | — | $110.6M | ||
| Q4 24 | — | $111.1M | ||
| Q3 24 | — | $126.8M | ||
| Q2 24 | — | $144.7M | ||
| Q1 24 | — | $160.9M |
| Q4 25 | $-205.3M | $713.1M | ||
| Q3 25 | $-155.8M | $764.0M | ||
| Q2 25 | $-206.5M | $736.0M | ||
| Q1 25 | $-185.8M | $685.1M | ||
| Q4 24 | $-1.1B | $631.2M | ||
| Q3 24 | $-1.1B | $613.3M | ||
| Q2 24 | $-980.2M | $574.8M | ||
| Q1 24 | $-893.9M | $573.6M |
| Q4 25 | $2.9B | $1.3B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.7B | $1.1B | ||
| Q4 24 | $1.7B | $1.0B | ||
| Q3 24 | $1.8B | $996.3M | ||
| Q2 24 | $1.9B | $942.5M | ||
| Q1 24 | $1.8B | $981.6M |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.25× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $31.0M |
| Free Cash FlowOCF − Capex | $-36.6M | $11.4M |
| FCF MarginFCF / Revenue | -22.3% | 4.7% |
| Capex IntensityCapex / Revenue | 1.4% | 8.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | $31.0M | ||
| Q3 25 | $-66.3M | $40.0M | ||
| Q2 25 | $-58.3M | $17.9M | ||
| Q1 25 | $870.1M | $46.9M | ||
| Q4 24 | $-30.0M | $61.1M | ||
| Q3 24 | $-77.0M | $41.5M | ||
| Q2 24 | $-71.5M | $34.5M | ||
| Q1 24 | $70.8M | $33.4M |
| Q4 25 | $-36.6M | $11.4M | ||
| Q3 25 | $-69.7M | $21.2M | ||
| Q2 25 | $-59.6M | $-14.7M | ||
| Q1 25 | $868.4M | $16.5M | ||
| Q4 24 | $-33.8M | $35.4M | ||
| Q3 24 | $-77.5M | $17.8M | ||
| Q2 24 | $-78.8M | $14.2M | ||
| Q1 24 | $61.2M | $23.6M |
| Q4 25 | -22.3% | 4.7% | ||
| Q3 25 | -33.1% | 8.2% | ||
| Q2 25 | -33.3% | -5.7% | ||
| Q1 25 | 73.8% | 7.4% | ||
| Q4 24 | -15.8% | 14.8% | ||
| Q3 24 | -39.4% | 7.5% | ||
| Q2 24 | -42.2% | 6.5% | ||
| Q1 24 | 29.1% | 12.2% |
| Q4 25 | 1.4% | 8.0% | ||
| Q3 25 | 1.6% | 7.2% | ||
| Q2 25 | 0.7% | 12.7% | ||
| Q1 25 | 0.1% | 13.7% | ||
| Q4 24 | 1.8% | 10.7% | ||
| Q3 24 | 0.3% | 9.9% | ||
| Q2 24 | 4.0% | 9.2% | ||
| Q1 24 | 4.6% | 5.1% |
| Q4 25 | — | 1.19× | ||
| Q3 25 | -4.17× | 0.85× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | 1.00× | 1.11× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
TGLS
| Product Sales | $164.2M | 67% |
| Fixed Price Contracts | $81.1M | 33% |
| Related Party | $692.0K | 0% |
